Bupropion-NaltrexoneMarch 14, 2026

Bupropion-Naltrexone Side Effects and How to Manage Them

Bupropion-Naltrexone Side Effects and How to Manage Them

Bupropion-naltrexone is one of the most widely prescribed combination medications for chronic weight management. Clinical trials show it can produce meaningful weight loss of around 5–10% of total body weight when paired with lifestyle changes. Side effects are common, and most patients receive little practical guidance on how to handle them.

What Bupropion-Naltrexone Does in Your Body

It helps to understand why this medication causes them in the first place. Bupropion-naltrexone combines two drugs that act on different parts of your brain's reward and appetite systems.

  • Bupropion is a dopamine and norepinephrine reuptake inhibitor. It was originally developed as an antidepressant and later approved for smoking cessation. In this combination, it stimulates pro-opiomelanocortin (POMC) neurons in the hypothalamus, which is a brain region that regulates hunger and energy expenditure. That stimulation reduces appetite and increases the number of calories your body burns at rest.
  • Naltrexone is an opioid receptor antagonist. On its own, it's used to treat alcohol and opioid dependence. In this combination, it blocks the auto-inhibitory feedback loop that would normally shut down the POMC neurons that bupropion activates. Naltrexone keeps bupropion's appetite-suppressing effect from fading over time.

The side effects you experience are largely a downstream result of these mechanisms. Understanding this helps you anticipate which side effects are likely, why they tend to diminish over time as your body adjusts, and when a symptom might signal a need for medical evaluation.

Bupropion-naltrexone treatment result reflected as a woman in athletic wear measures her slim waist with a tape measure.

The Dose Escalation Schedule: Your Built-In Side Effect Buffer

One of the most important things to know about bupropion-naltrexone is that you don't start at the full dose. The standard prescribing protocol uses a four-week titration schedule specifically designed to ease your body into the medication and minimize early side effects. During week one, you take one tablet each morning. That's 8 mg of naltrexone and 90 mg of bupropion. In week two, you add a second tablet before dinner, bringing you to two tablets daily. Week three adds a second morning tablet for a total of three. By week four, you reach the maintenance dose of two tablets in the morning and two before dinner. Four tablets daily, totaling 32 mg of naltrexone and 360 mg of bupropion.

This gradual ramp-up exists because clinical data consistently show that most side effects peak during the first two weeks and then decline significantly. The highest incidence of nausea onset occurs during week one, with roughly 9% of patients reporting it during that initial period. The median duration of even moderate nausea was only about 9 days. If you're tempted to skip ahead to the full dose to "get results faster," resist that urge. The escalation schedule is a clinical tool designed to keep you on the medication long enough for it to work. Patients who follow it are significantly more likely to tolerate the adjustment period and stay on treatment.

Common Side Effects: What Most People Experience

The Contrave Obesity Research (COR) clinical trial program, which included over 4,500 participants across multiple Phase 3 trials, provides the most robust data on what side effects to expect. Here's what showed up most frequently, and what to do about each one.

Nausea

Nausea is the most commonly reported side effect of bupropion-naltrexone. In the COR-I trial, 29.8% of participants taking the standard dose experienced nausea, compared to just 5.3% on placebo.

How to manage it: Take your dose with food rather than on an empty stomach. Avoid fatty, spicy, or heavy meals around dosing time. Bland, moderate portions work best. If nausea hits, small sips of ginger tea or flat ginger ale can help settle your stomach. Some patients find that temporarily splitting the evening dose reduces the intensity. If nausea persists beyond the first two to three weeks or becomes severe, talk to your prescriber. They may recommend a temporary anti-nausea medication or a slower titration.

Constipation

28.6% of patients reported constipation during the buildup phase. Bupropion's effect on norepinephrine signaling can slow gut motility, and the dietary changes that often accompany weight loss medication, such as eating less, can compound the issue.

How to manage it: Hydration is your first line of defense. Aim for at least 8–10 glasses of water daily. Increase your fiber intake gradually through whole grains, legumes, fruits, and vegetables, but don't go from low-fiber to high-fiber overnight, as that can cause bloating. Regular physical activity, even a 20-minute daily walk, helps stimulate bowel movement. If dietary changes aren't enough after a week, an over-the-counter stool softener like docusate or a gentle osmotic laxative like polyethylene glycol (MiraLAX) is generally safe, but confirm with your prescriber first.

Headache

Headaches affected roughly 19.4% of patients and were consistently reported across the COR trials. They're most common during the first two weeks of treatment as your body adjusts to bupropion's effects on norepinephrine and dopamine.

How to manage it: Over-the-counter pain relievers like acetaminophen (Tylenol) or ibuprofen (Advil) are appropriate for occasional headaches during the adjustment period. Dehydration is a frequent but overlooked trigger. Many patients beginning a weight management program inadvertently drink less water as they eat less food. Keep a water bottle nearby and set reminders if needed. If headaches are persistent or severe, or if they are accompanied by visual changes or a pounding sensation, contact your healthcare provider, as this could signal a blood pressure change that needs evaluation.

Dizziness

Dizziness is typically mild and more common during the titration period. It's related to bupropion's effects on blood pressure and the central nervous system, as well as its adjustment to new neurotransmitter levels.

How to manage it: Stand up slowly from seated or lying positions, particularly in the morning or after meals. Avoid alcohol, which magnifies dizziness and is generally discouraged during bupropion-naltrexone treatment. If dizziness becomes frequent or severe enough to affect your daily activities, your prescriber should evaluate your blood pressure and may adjust the titration schedule.

Dry Mouth

Dry mouth is a well-known effect of bupropion's norepinephrine activity. It's more annoying than dangerous, but persistent dry mouth can increase the risk of dental problems if left unaddressed.

How to manage it: Frequent small sips of water throughout the day are the simplest remedy. Sugar-free gum or lozenges can stimulate saliva production. Avoid caffeine and alcohol, both of which worsen dry mouth. If it persists, a saliva substitute spray can provide relief.

Insomnia and Sleep Disruption

Bupropion is a stimulating antidepressant, and its effects on dopamine and norepinephrine can interfere with sleep, particularly if you take your evening dose too close to bedtime.

How to manage it: The prescribing label recommends taking your evening dose before dinner, not at bedtime. This gives the stimulating effect time to taper off before you try to sleep. Practicing consistent sleep hygiene helps: going to bed and waking up at the same time each day, keeping your bedroom cool and dark, and avoiding screens for at least 30 minutes before bed. If insomnia is persistent and significantly affecting your quality of life, discuss it with your prescriber. They may adjust your dosing schedule or recommend a short-term sleep aid.

Less Common but Notable Side Effects

Increased Heart Rate and Blood Pressure

Bupropion-naltrexone can modestly raise resting heart rate and blood pressure. Systolic blood pressure improvements were smaller in the treatment group than in the placebo group, and a large cardiovascular outcomes trial was conducted specifically to evaluate cardiovascular safety. If you have a home blood pressure monitor, periodic self-checks are useful.

Vomiting

While nausea is common, actual vomiting is less frequent, occurring in roughly 10–15% of patients in clinical trials. It follows the same pattern as nausea: most likely during weeks one through three, and usually resolves as the body adjusts.

How to manage it: The same strategies for nausea apply. If vomiting is frequent enough to affect your ability to eat or stay hydrated, contact your prescriber. Persistent vomiting may require a temporary dose reduction or a slower titration approach.

Bupropion-naltrexone for weight management depicted by a woman in workout clothes holding an apple while measuring her waist.

Diarrhea and Abdominal Pain

Some patients experience loose stools or stomach discomfort, particularly during the early weeks. This is generally mild and self-limiting.

How to manage it: A bland diet and adequate hydration are usually sufficient. Avoid high-fat or greasy foods during flare-ups. If diarrhea is severe, persistent, or accompanied by fever, seek medical advice.

Hot Flashes

Hot flashes are reported by some patients, likely related to the medication's effects on central nervous system thermoregulation. They're typically mild and infrequent, and they tend to diminish over the first few weeks. If they're bothersome, wearing layered clothing, keeping a fan nearby, and avoiding known triggers like caffeine, alcohol, and spicy foods can help. Hot flashes that are persistent or severe should be mentioned to your prescriber, though they rarely require treatment changes on their own.

Serious Side Effects: When to Contact Your Doctor Immediately

Seizures

Bupropion carries a dose-dependent seizure risk. At the doses used in bupropion-naltrexone (up to 360 mg daily), the seizure rate in clinical trials was approximately 0.1%, comparable to other commonly prescribed antidepressants. However, the risk increases with certain factors: a history of seizures or epilepsy, eating disorders, heavy alcohol use, or abrupt withdrawal from alcohol or sedatives.

What to do: If you experience a seizure, seek emergency medical care immediately. Before starting treatment, make sure your prescriber knows your full medical history, including any history of seizures, eating disorders, or heavy alcohol use.

Mood Changes, Suicidal Thoughts, and Psychiatric Symptoms

Because bupropion was originally developed as an antidepressant, the FDA requires a boxed warning about suicidal thoughts and behavior, particularly in young adults (ages 18–24) during the first few months of treatment. A pooled analysis of five randomized clinical trials evaluated psychiatric adverse events across more than 3,200 patients. It found that overall psychiatric adverse event rates were comparable between the bupropion-naltrexone group and placebo, and that measures of depression and suicidality generally improved with treatment. Watch for new or worsening anxiety, agitation, panic attacks, irritability, hostility, impulsivity, restlessness, or any thoughts of self-harm.

What to do: If you or someone close to you notices significant mood changes, especially during the first few weeks, contact your prescriber immediately. Don't wait for your next scheduled appointment.

Liver Injury

Naltrexone carries a historical FDA warning about hepatotoxicity at high doses, though the evidence at standard bupropion-naltrexone doses is reassuring. The combination has not been linked to clinically apparent liver injury, and no cases of acute liver failure have been attributed to it. Bupropion-naltrexone-associated weight loss may improve liver enzyme levels in patients with elevated baseline values.

What to do: Report symptoms like upper abdominal pain, unusual fatigue, dark-colored urine, or yellowing of the skin or eyes to your doctor. Routine liver function monitoring may be recommended, particularly if you have pre-existing liver conditions.

Severe Allergic Reactions

Anaphylaxis and serious skin reactions have been reported rarely with bupropion. Signs include rash, hives, swelling of the face, lips, tongue, or throat, difficulty breathing or swallowing, and tightness in the chest.

What to do: Seek emergency medical care immediately if you experience any of these symptoms. Notably, allergic reactions to bupropion can have a delayed onset. There is a latency period of 10 to 20 days, meaning a reaction can appear well after you've started taking the medication.

Opioid Interaction Risk

This is one of the most critical safety considerations. Naltrexone blocks opioid receptors, which means taking opioid medications while on bupropion-naltrexone is dangerous. Because the opioid effects are blocked, someone might take increasingly higher doses to try to feel relief, dramatically increasing the risk of overdose, respiratory depression, and death.

What to do: Tell your prescriber about any opioid use before starting treatment. If you need surgery or acute pain management while taking bupropion-naltrexone, inform every healthcare provider involved that you're on an opioid antagonist. Alternative pain management strategies will need to be arranged.

What the First 12 Weeks Actually Look Like

Clinical data and patient experience converge on a fairly predictable pattern during the early months of treatment.

  1. Weeks 1–2 are typically the hardest. Nausea, headache, and dizziness are at their peak while your body adjusts to the medication at a lower dose. This is normal. Most patients who push through this window find that symptoms ease significantly.
  2. Weeks 3–4 bring the dose escalation to maintenance level. Some patients experience a brief return of symptoms as the dose increases, but it's generally milder than the initial adjustment. By the end of week four, most common side effects have either resolved or become tolerable.
  3. Weeks 5–12 are when most patients settle into a steady state. Side effects that persist beyond this point are worth discussing with your prescriber, as they may warrant dose adjustment or additional management strategies. This is also the window where you should be seeing measurable weight loss. The FDA-approved prescribing information recommends evaluating treatment response at 12 weeks, and if you haven't lost at least 5% of your body weight by 12 weeks, your provider may recommend discontinuation.

Platforms like Harbor are designed to support patients through exactly this kind of adjustment period. Harbor pairs physician-guided weight management with FDA-approved treatments and ongoing medical monitoring, recognizing that pharmacotherapy produces the most durable results when embedded within a broader framework of nutritional guidance, behavioral support, and regular clinical follow-up. Having a care team that proactively checks in during those critical first weeks can make the difference between staying on treatment and joining that 52.7% discontinuation statistic.

Bupropion-naltrexone consultation shown as a doctor in a white coat measures a patient's waist circumference with a yellow tape measure.

Every medication involves a trade-off between benefits and side effects, and bupropion-naltrexone is no exception. The clinical evidence is clear that it works, but it's equally clear that the first few weeks require patience and proactive management. The patients who succeed on this medication tend to share a few traits: they understand the dose escalation schedule and follow it, they expect the early side effects and have a plan for managing them, they maintain open communication with their healthcare team, and they treat the medication as one component of a broader lifestyle approach rather than a standalone solution. If you're considering bupropion-naltrexone or you've just started it, arm yourself with information. Know what to expect, know what's normal, know what's not, and know who to call. Side effects are part of the process, but they don't have to be the reason you stop.

Sources: